SCTL Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (5 Apr 2024 @ 16:00):

Stats
Today's Volume	512 703
Average Volume	1.14M
Market Cap	116.13M
EPS	$0 ( 2024-03-27 )
Next earnings date	( $-0.0300 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-7.86
ATR14	$0.00200 (0.18%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-08	Arens Mathew Paul	Sell	19 676 396	Common Stock
2024-04-08	Arens Mathew Paul	Sell	20 000	Stock Option (Right to Buy)
2024-04-08	Arens Mathew Paul	Sell	1 250 000	Pre-Funded Warrant (right to buy)
2024-04-08	Weisman Wayne	Sell	234 982	Common Stock
2024-04-08	Weisman Wayne	Sell	73 620	Common Stock

INSIDER POWER
-38.94
Last 97 transactions
Buy: 17 853 836 \| Sell: 28 337 731

Volume Correlation

Long: 0.14 (neutral)

Short: 0.00 (neutral)

Signal:(41.76) Neutral

Societal CDMO, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Societal CDMO, Inc. Correlation - Currency/Commodity

0.22
( neutral )

0.05
( neutral )

0.00
( neutral )

-0.19
( neutral )

Societal CDMO, Inc. Financials

Annual	2023
Revenue:	$94.64M
Gross Profit:	$18.50M (19.54 %)
EPS:	$-0.140

Q4	2023
Revenue:	$27.72M
Gross Profit:	$8.58M (30.94 %)
EPS:	$-0.00750

Q3	2023
Revenue:	$23.59M
Gross Profit:	$3.72M (15.77 %)
EPS:	$-0.0456

Q2	2023
Revenue:	$21.80M
Gross Profit:	$4.47M (20.51 %)
EPS:	$-0.0368

Financial Reports:

No articles found.

Societal CDMO, Inc.

Societal CDMO, Inc., a contract development and manufacturing organization, engages in the research and development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. The company was formerly known as Recro Pharma, Inc. and changed its name to Societal CDMO, Inc. in March 2022. Societal CDMO, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.